Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Fulton County Government sues multiple drug companies for supplying and distributing prescription drugs in GA at the alleged disregard of state laws and citizen's welfare
  • USA - English


News provided by

FIRST CLASS, INC.

Apr 06, 2015, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Rod Edmond, Attorney-at-Law;       Edmond, Lindsay & Hoffler, LLP; Atlanta, GA
Dr. Rod Edmond, Attorney-at-Law; Edmond, Lindsay & Hoffler, LLP; Atlanta, GA

Atlanta, Georgia (PRWEB) April 06, 2015 -- A conglomerate of companies supplying and distributing prescription drugs in Fulton County and throughout the state of Georgia under the brand name of Cardinal Health Companies, McKesson Corporation and AmeriSourceBergen Drug Corporation are being sued by Fulton County for allegedly causing injuries and engaging in a course of conduct that violates Georgia law. The law suit was filed by Fulton County Government in the Superior Court of Fulton County on Wednesday, March 10, 2015 – Case No. 2015CV258133.

This is a statewide problem, and Fulton County (GA) had to take action to stem the tide of its financial losses from the prescription drug abuse epidemic.

Post this

According to court documents, the civil action addresses the epidemic of prescription opioid drug abuse and addiction in the State of Georgia and the related costs to the County. According to the Center for Disease Control and Prevention (CDCP), more than 16,500 people died in 2010 in the United States from opioid painkillers, more than from heroin and cocaine combined, and prescription painkillers are now the nation’s number one drug problem.

The prescription drug distribution system is a sprawling one that involves approximately 800 companies that sell billions of pills annually as stated in the complaint presented to the court. In 2012, sales of prescription painkillers in the United States reached $8.5 billion according to industry reports according to court documents..

The Georgia Bureau of Investigation (GBI) has reported that of the 686 drug overdose deaths in 2012, 592 (86%) were prescription drugs. The annual cost to Fulton County from the abuse of prescription drug is estimated to be millions of dollars. These costs are from expenses for Fulton County’s hospitals and health agencies, courts, social service agencies, jails and prisons, etc. according to court documents.

According to further court documents,. Cardinal had sent 2,050,000 oxycodone pills to one store in Florida where the population in the town was 53,000. These defendants have supplied controlled substances to rogue drugstores and clinics which disburse controlled substances based on bogus prescriptions from physicians who are prescribing for illegitimate purposes.as stated in court documents.

The complaint found in court documents alleges that Defendants violated provisions within the Georgia Controlled Substances Act and the Georgia Pharmacy Practice Act. It alleges that Defendants have, by their acts and omissions, caused and substantially contributed to damages to Fulton County by violating Georgia law, by creating conditions which contribute to the violations of Georgia laws by others, and by their negligent and/or reckless disregard of the customs, standards and practices within their own industry.

This civil action has requested that the Court issue a temporary and permanent injunction which will mandate the defendants to inform the Georgia State Board of Pharmacy of all suspicious orders for controlled substances; direct the defendants to submit their system of determining suspicious drug orders; and enjoin defendants from distributing in Georgia any controlled substance for illegitimate medical purpose. The plaintiff, Fulton County, also asks to recover costs, losses and damages; reimbursement for litigation costs; and a trial by jury.

The lawsuit was filed on behalf of Fulton County by Attorneys Roderick Edmond of Edmond, Lindsay and Hoffler, LLP in Atlanta, Georgia and Mark Tate of the Tate Law Group in Savannah, Georgia. Mr. Tate says, “This litigation gives Fulton County the opportunity to force the Defendants who have profited handsomely on the ticket of Fulton County taxpayers to shift the burden of costs to where it should be.” Mr. Edmond commented that, “This is a statewide problem, and Fulton County had to take action to stem the tide of its financial losses from the prescription drug abuse epidemic.”

BUNNIE JACKSON-RANSOM, FIRST CLASS, INC., http://www.fclassinc.com, +1 (404) 505-8188, [email protected]

Modal title

Hydrocodone Pills
Hydrocodone Pills
Oxycodone Pills
Oxycodone Pills
Mark Tate, Attorney-at-Law; Tate Law Group, Savannah, GA
Mark Tate, Attorney-at-Law; Tate Law Group, Savannah, GA
Hydrocodone Pills Oxycodone Pills Mark Tate, Attorney-at-Law; Tate Law Group, Savannah, GA

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.